About this journal
Aims and scope
Drug, Healthcare and Patient Safety is an international, peer reviewed, open access journal exploring patient safety issues in the healthcare continuum from diagnostic and screening interventions through to treatment, drug therapy and surgery.
The journal is characterized by the rapid reporting of reviews, original research, clinical, epidemiological and post-marketing surveillance studies, risk management, health literacy and educational programs across all areas of healthcare delivery. Also, guidelines on data requirements to assure acceptable safety levels in license applications, post marketing protocols on monitoring safety, on managing associated morbidity and mortality are key topics. Adverse reaction case reports, animal and in vitro toxicity studies are also welcome. Balancing risk, effectiveness, patient satisfaction and quality of life and the development and testing of new interventions to optimize clinical outcomes in disease management are major areas of interest for the journal.
Drug, Healthcare and Patient Safety will no longer consider meta-analyses for publication.
Journal metrics
Usage
- 41K annual downloads/views
Citation metrics
- 2.2 (2023) Impact Factor
- Q2 Impact Factor Best Quartile
- 2.2 (2023) 5 year IF
- 4.1 (2023) CiteScore (Scopus)
- Q2 CiteScore Best Quartile
- 1.145 (2023) SNIP
- 0.571 (2023) SJR
Understanding and using journal metrics
Journal metrics can be a useful tool for readers, as well as for authors who are deciding where to submit their next manuscript for publication. However, any one metric only tells a part of the story of a journal’s quality and impact. Each metric has its limitations which means that it should never be considered in isolation, and metrics should be used to support and not replace qualitative review.
We strongly recommend that you always use a number of metrics, alongside other qualitative factors such as a journal’s aims & scope, its readership, and a review of past content published in the journal. In addition, a single article should always be assessed on its own merits and never based on the metrics of the journal it was published in.
For more details, please read the Author Services guide to understanding journal metrics.
Journal metrics in brief
Usage and acceptance rate data above are for the last full calendar year and are updated annually in February. Speed data is updated every six months, based on the prior six months. Citation metrics are updated annually mid-year. Please note that some journals do not display all of the following metrics (find out why).
- Usage: the total number of times articles in the journal were viewed by users of Taylor & Francis Online in the previous calendar year, rounded to the nearest thousand.
Citation Metrics
- Impact Factor*: the average number of citations received by articles published in the journal within a two-year window. Only journals in the Clarivate Science Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI), Arts and Humanities Citation Index (AHCI) and the Emerging Sources Citation Index (ESCI) have an Impact Factor.
- Impact Factor Best Quartile*: the journal’s highest subject category ranking in the Journal Citation Reports. Q1 = 25% of journals with the highest Impact Factors.
- 5 Year Impact Factor*: the average number of citations received by articles in the journal within a five-year window.
- CiteScore (Scopus)†: the average number of citations received by articles in the journal over a four-year period.
- CiteScore Best Quartile†: the journal’s highest CiteScore ranking in a Scopus subject category. Q1 = 25% of journals with the highest CiteScores.
- SNIP (Source Normalized Impact per Paper): the number of citations per paper in the journal, divided by citation potential in the field.
- SJR (Scimago Journal Rank): Average number of (weighted) citations in one year, divided by the number of articles published in the journal in the previous three years.
Speed/acceptance
- From submission to first decision: the average (median) number of days for a manuscript submitted to the journal to receive a first decision. Based on manuscripts receiving a first decision in the last six months.
- From submission to first post-review decision: the average (median) number of days for a manuscript submitted to the journal to receive a first decision if it is sent out for peer review. Based on manuscripts receiving a post-review first decision in the last six months.
- From acceptance to online publication: the average (median) number of days from acceptance of a manuscript to online publication of the Version of Record. Based on articles published in the last six months.
- Acceptance rate: articles accepted for publication by the journal in the previous calendar year as percentage of all papers receiving a final decision.
For more details on the data above, please read the Author Services guide to understanding journal metrics.
*Copyright: Journal Citation Reports®, Clarivate Analytics
†Copyright: CiteScore™, Scopus
Editorial board
Editor-in-Chief:
Dr Rajender R Aparasu, Department of Pharmaceutical Health Outcomes and Policy, College of Pharmacy, University of Houston, United States
Associate Editors-in-Chief:
Professor Siew Siang Chua, School of Pharmacy, Taylor's University, Malaysia
Dr Hemalkumar B Mehta, Department of Epidemiology, Johns Hopkins University, United States
Editorial Board:
Dr Lise Aagaard, The Danish Council on Ethics, National Committee on Health Research Ethics, and Medical Research Ethics Committee, Denmark
Dr Syed Imran Ahmed, School of Pharmacy, College of Science, University of Lincoln, United Kingdom
Professor Chul Ahn, Clinical Sciences, UT Southwestern Medical Center, United States
Dr Bontha Babu, Socio-Behavioural & Health Systems Research, Indian Council of Medical Research, India
Professor Charles Bennett, Department of Clinical Pharmacy and Outcomes Sciences, South Carolina College of Pharmacy, United States
Dr Jongwha Chang, Department of Pharmaceutical Sciences, Irma Lerma Rangel School of Pharmacy, Texas A&M University, College Station, TX, United States
Professor Giorgio Lorenzo Colombo, Deptartment of Drug Sciences, University of Pavia, Italy
Dr Robin Jacobs, College of Osteopathic Medicine, Nova Southeastern University, United States
Dr Gerald Klein, Clinical Research, Medsurgpi LLC, Adjunct Professor of Pharmacology and Toxicology Brody School of Medicine at East Carolina University, United States
Dr Peter Koulen, Ophthalmology, University of Missouri Kansas City, School of Medicine, United States
Professor Peter Martin, Psychiatry and Pharmacology, Vanderbilt Psychiatric Hospital, Vanderbilt University School of Medicine, United States
Professor Raffaele Serra, Department of Medical and Surgical Sciences, University Magna Graecia of Catanzaro, Italy
Dr Bach Tran, Department of Health Economics, Hanoi Medical University, Vietnam
Prof. Dr. Vladimir Trkulja, Department of Pharmacology, Zagreb University School of Medicine, Croatia
Professor Chiara Verbano, Department of Management and Engineering, University of Padova, Italy
Professor Karen Wagner, Psychiatry & Behavioral Sciences, The University of Texas Medical Branch, United States
Professor John Zaia, Centre for Gene Therapy, City of Hope, United States
Abstracting and indexing
Drug, Healthcare and Patient Safety is indexed/tracked/covered by the following services:
Directory of Open Access Journals (DOAJ)
EMBASE (Elsevier)
Pubmed (NLM)
PubMed Central Selective Deposit Medicine & Health (NLM)
Scopus (Elsevier)
Open access
Drug, Healthcare and Patient Safety is an open access journal and only publishes open access articles. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research.
Why choose open access?
- Increase the discoverability and readership of your article
- Make an impact and reach new readers, not just those with easy access to a research library
- Freely share your work with anyone, anywhere
- Comply with funding mandates and meet the requirements of your institution, employer or funder
- Rigorous peer review for every open access article
Article Publishing Charges (APC)
To publish open access in this journal you may be asked to pay an Article Publishing Charge (APC). You may be able to publish your article at no cost to yourself or with a reduced APC if your institution or research funder has an open access agreement or membership with Taylor & Francis. Discounts and waivers may also be available for researchers in selected countries when publishing in open access journals.
Use our APC finder to calculate your article publishing charge
Continuous
Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site (link opens in a new window) Instructions for authors